Unless you decide to deactivate cookies by visiting the site www.advicenne.com (the “Website”), you agree that the Advicenne company can use them for the Website’s requirements. You can deactivate cookies at any time at no cost by using the deactivation methods detailed below, although you should note that the deactivation of all or part of these cookies can reduce or prevent access to all or part of the features proposed by this Website.
A “cookie” is a small information file deposited on the device (e.g., computer, smartphone) of the individual visiting the Website (the “User“). This file contains information like the User’s domain name, the User’s Internet provider, the User’s operating system, and the date and time of access. Cookies in no way risk damaging the User’s device.
Through cookies, Advicenne may process the User’s personal data as regards their visits to the Website, such as the pages viewed and the searches performed. This information enables Advicenne to improve the content of the Website and Users’ browsing experience on the Website.
1. List of cookies on the Website:
SERVERID68971: Placed by the host; this balances out traffic on the web server.
_ga: Registers a single identifier used to generate statistical data on the way Users interact with the Website. This cookie is deleted 1 year after it is registered.
_gat: Used by Google Analytics to radically reduce the request rate. This cookie is deleted 1 day after it is registered.
_gid: Registers a single identifier used to generate statistical data on the way Users interact with the Website. This cookie is deleted 1 day after it is registered.
_gat_gtag_UA_28487651_5: Site identification code designed to trace visits. This cookie is deleted 24 hours after it is registered.
pll_language: Registers the language selected by the User.
Unless otherwise indicated, cookies are stored for a maximum period of 13 months. At the end of this period, Users must give their consent again for the cookie concerned to be deposited.
2. Configuring your browser:
Users can configure their browsers according to the procedures shown below, thus deciding whether cookies can be deposited on their devices or be rejected, either systematically or according to their senders. Users can also configure their browsing software to propose the acceptance or refusal of cookies each time, before a cookie can be registered on their device.
Advicenne informs Users that in this case, all of its browser software functions may not be available.
If Users refuse the registration of cookies on their devices, of if they delete any that have been deposited, they are informed that their browsing and experience on the Website may be restricted. This may also be the case if the company or any of its service providers are unable to recognize, for technical compatibility purposes, the type of browser used by the device, the language and display parameters or the country from which the device appears to be connected to the Internet.
If need be, Advicenne declines all responsibility for any consequences linked to the worsened performance of the Website and any services proposed by Advicenne, which result from (i) the User’s refusal of cookies or (ii) the impossibility for Advicenne to register or view the cookies required for their functioning because of the User’s decision.
Users can decide to express or modify their preferences regarding cookies at any time.
3. How to activate your choice according to the browser you use
With Internet Explorer™: Click here for more information
With Safari™: Click here for more information
With Chrome™: Click here for more information
With Firefox™: Click here for more information
With Opera™: Click here for more information
4. How do you manage your choices on a smartphone?
Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.
© 2020 Advicenne